Back to Search Start Over

Free 25-hydroxyvitamin D is low in obesity, but there are no adverse associations with bone health.

Authors :
Walsh, Jennifer S.
Evans, Amy L.
Bowles, Simon
Naylor, Kim E.
Jones, Kerry S.
Schoenmakers, Inez
Jacques, Richard M.
Eastell, Richard
Source :
American Journal of Clinical Nutrition; 6/1/2016, Vol. 103 Issue 6, p1465-1471, 7p, 3 Charts, 1 Graph
Publication Year :
2016

Abstract

Background: The mechanism and clinical significance of low circulating 25-hydroxyvitamin D [25(OH)D] in obese people are unknown. Low total 25(OH)D may be due to low vitamin D-binding proteins (DBPs) or faster metabolic clearance. However, obese people have a higher bone mineral density (BMD), which suggests that low 25(OH)D may not be associated with adverse consequences for bone. Objective: We sought to determine whether 1) vitamin D metabolism and 2) its association with bone health differ by body weight. Design: We conducted a cross-sectional observational study of 223 normal-weight, overweight, and obese men and women aged 25-75 y in South Yorkshire, United Kingdom, in the fall and spring. A subgroup of 106 subjects was also assessed in the winter. We used novel techniques, including an immunoassay for free 25(OH)D, a stable isotope for the 25(OH)D<subscript>3</subscript> half-life, and high-resolution quantitative tomography, to make a detailed assessment of vitamin D physiology and bone health. Results: Serum total 25(OH)D was lower in obese and overweight subjects than in normal-weight subjects in the fall and spring (geometric means: 45.0 and 40.8 compared with 58.6 nmol/L, respectively; P < 0.001) but not in the winter. Serum 25(OH)D was inversely correlated with body mass index (BMI) in the fall and spring and in the winter. Free 25(OH)D and 1,25-dihydroxyvitamin D [1,25(OH)<subscript>2</subscript>D] were lower in obese subjects. DBP, the DBP genotype, and the 25(OH)D<subscript>3</subscript> half-life did not differ between BMI groups. Bone turnover was lower, and bone density was higher, in obese people. Conclusions: Total and free 25(OH)D and 1,25(OH)<subscript>2</subscript>D are lower at higher BMI, which cannot be explained by lower DBP or the shorter half-life of 25(OH)D<subscript>3</subscript>. We speculate that low 25(OH)D in obesity is due to a greater pool of distribution. Lower 25(OH)D may not reflect at-risk skeletal health in obese people, and BMI should be considered when interpreting serum 25(OH)D as a marker of vitamin D status. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
00029165
Volume :
103
Issue :
6
Database :
Complementary Index
Journal :
American Journal of Clinical Nutrition
Publication Type :
Academic Journal
Accession number :
115982788
Full Text :
https://doi.org/10.3945/ajcn.115.120139